Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The addition of anticholinergics to
2 agonist
inhalations remains controversial in the treatment of children and
adolescents with asthma exacerbations. To examine the efficacy of three
management strategies for adding anticholinergics to
2
agonists, Plotnick and Ducharme (p 971) systematically reviewed 10 randomised controlled trials, including single dose, multiple doses
(predetermined protocol), and multiple doses (flexible protocol). Only
the addition of multiple doses of anticholinergics to
2
agonists in a predetermined protocol reduced the risk of hospital
admission (by 30%) and improved pulmonary function tests. Eleven
children would need to be treated to avoid one admission. The use of
anticholinergics in mild to moderate asthma is not supported by the
available evidence. The number and size of pooled studies remain small,
thus the conclusions are subject to change with future larger trials.
2 agonists for treating acute childhood and adolescent asthma? A systematic review